Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Funding
Sign In Sign Up
Night Mode
What Are the Key Challenges Facing the AAV Vector-based Gene Therapy Market?
Despite its promise, the AAV vector-based gene therapy market faces significant challenges that must be addressed for the field to reach its full potential. From pricing to immunogenicity, these barriers affect developers, payers, and patients alike. High treatment costs—often exceeding millions of dollars per patient—raise access and reimbursement concerns. Payers are scrutinizing...
0 Comments ·0 Shares ·113 Views ·0 Reviews
Please log in to like, share and comment!